You are here: All Products  > Zymeworks’ HER2 Bispecific Under Review in China for Rare HER2 Cancers

Zymeworks’ HER2 Bispecific Under Review in China for Rare HER2 Cancers

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products